Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/REGENERX-BIOPHARMACEUTICA-120787471/news/RegeneRx-Partner-Signs-LOI-with-Global-Ophthalmology-CRO-for-Two-Phase-3-Clinical-Trials-in-Neurotro-41011456/?utm_source=whatsapp&utm_medium=social&utm_campaign=share